Representing one of four sites across the United States, principal investigator and former Naval Officer Dr. Robert Frenck at Cincinnati Children’s Hospital is leading the Phase I/2 trials investigating the BNT 162 COVID-19 vaccine. Developed by a German biotech...
Cincinnati Children’s Hospital Medical Center
Category
Cincinnati Children’s Allocates $450K to Important COVID-19-Focused Studies
Cincinnati Children’s now dedicates $450,000 to launch six COVID-19-centered research initiatives. Six proposals out of a total of 35 proposals were selected in a competitive process. The six projects include 1) AI tool that utilizes natural language processing and...
Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib
Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...
Study at Cincinnati Children’s Hospital Medical Center Opens New Avenues for More Effective Autoimmune Therapies
Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases. In a study published online Dec. 17, 2019, researchers at Cincinnati...
Cincinnati Children’s Hospital Investigators Develop PERSEVERE to Predict Mortality Levels from Sepsis
Cincinnati Children’s Hospital Medical Center investigators have developed a new rapid blood assay that can predict mortality risk levels from sepsis and could help inform precision medicine to treat the infections. They have filed patents through the institution’s...